Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $94.35 | Total: $471.75 |
| 1 | 10 | $79.92 | Total: $799.20 |
| 1 | 25 | $67.71 | Total: $1,692.75 |
| 1 | 50 | $57.72 | Total: $2,886.00 |
| 1 | 100 | $49.95 | Total: $4,995.00 |
Overview
Torbafylline, a xanthine derivative, is a phosphodiesterase (PDE) inhibitor that attenuates burn-induced protein hydrolysis in rat skeletal muscle through activation of the PDE4cAMPEPACPI3KAkt pathway, and inhibits the enhanced ubiquitin-proteasome-dependent protein hydrolysis in skeletal muscle of cancer- and sepsis-prone rats.
Chemical Properties
| Molecular Formula | C16H26N4O4 |
| Molecular Weight | 338.4 |
| CAS Numbers | 105102-21-4 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(OCC)N1C2=C(N(C)C(=O)N(CCCCC(C)(C)O)C2=O)N=C1 |
Storage and Handling
0C Short Term, -20C Long Term
References
Okyayuz-Baklouti I. The effects of torbafylline on blood flow, pO2 and function of rat ischaemic skeletal muscle. Eur J Pharmacol. 1989;166[1] 75-86.